MELA Reports Positive Reception for its Optical Melanoma Diagnostic Device at Mount Sinai Winter Dermatology Symposium
December 09, 2013 at 12:49 PM EST
MELA Sciences (NASDAQ: MELA ) received positive dermatologist feedback from its second Clinical Advisory Meeting held in conjunction with the 16th Annual Mount Sinai Winter Dermatology Symposium last
